By Sheri Kasprzak
New York, Oct. 4 - Dynavax Technologies Corp. negotiated the terms of a $27.28 million direct placement.
The offering includes up to 6.2 million shares at $4.40 each. The price per share is par with the company's closing stock price on Tuesday.
The shares are being sold under the company's shelf registration.
Underwriter Pacific Growth Equities, LLC has a greenshoe for up to 930,000 shares.
The deal is scheduled to close Oct. 10.
Dynavax, based in Berkeley, Calif., develops treatments for cancer and allergies, and it is developing a vaccine for hepatitis B.
| Issuer: | Dynavax Technologies Corp.
|
| Issue: | Stock
|
| Amount: | $27.28 million
|
| Shares: | 6.2 million
|
| Greenshoe: | For 930,000 shares
|
| Price: | $4.40
|
| Warrants: | No
|
| Underwriter: | Pacific Growth Equities, LLC
|
| Pricing date: | Oct. 4
|
| Settlement date: | Oct. 10
|
| Stock symbol: | Nasdaq: DVAX
|
| Stock price: | $4.40 at close Oct. 3
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
